Onset of action of olanzapine-fluoxetine combination for treatment-resistant depression

被引：0
|
作者：
Dube, S
Andersen, SW
Briggs, SD
Van Campen, LE
Sanger, TM
Thase, ME
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [31] Olanzapine/fluoxetine combination for treatment resistant depression with current SSRI failure
    Corya, S
    Case, M
    Briggs, S
    Tohen, M
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S162 - S163
  • [32] A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder
    Thase, Michael E.
    Corya, Sara A.
    Osuntokun, Olawale
    Case, Michael
    Henley, David B.
    Sanger, Todd M.
    Watson, Susan B.
    Dube, Sanjay
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (02) : 224 - 236
  • [33] Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
    Luan, Shuxin
    Wan, Hongquan
    Wang, Shijun
    Li, He
    Zhang, Baogang
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 609 - 620
  • [34] Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression
    Dube, Sanjay
    Tollefson, Gary D.
    Thase, Michael E.
    Briggs, Susan D.
    Van Campen, Luann E.
    Case, Michael
    Tohen, Mauricio
    [J]. BIPOLAR DISORDERS, 2007, 9 (06) : 618 - 627
  • [35] A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Corya, SA
    Williamson, D
    Case, M
    Lin, D
    Tohen, M
    [J]. BIPOLAR DISORDERS, 2005, 7 : 44 - 44
  • [36] Addition of olanzapine for treatment-resistant depression
    Pitchot, W
    Ansseau, M
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (10): : 1737 - 1738
  • [37] A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Corya, SA
    Perlis, RH
    Keck, PE
    Lin, DY
    Case, MG
    Williamson, DJ
    Tohen, MF
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (05) : 798 - 806
  • [38] Safety metanalysis of olanzapine-fluoxetine combination versus placebo
    Dube, S
    Andersen, SW
    Clemow, DB
    Sanger, TM
    Tollefson, GD
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S184 - S184
  • [39] A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Corya, S
    Williamson, D
    Case, M
    Lin, D
    Tohen, M
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S139 - S139
  • [40] FLUOXETINE EFFICACY IN TREATMENT-RESISTANT DEPRESSION
    AMSTERDAM, JD
    MAISLIN, G
    POTTER, L
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (02): : 243 - 261
12345